Back to results
US 2019/0316133 A1Published application
Anti-Fibrinogen Aptamers and Uses Thereof
AssigneeLaboratoire Francais Du Fractionnement Et Des Biotechnologies
InventorAlexander SEIFERT
Life of this patent
Estimating the term…
Abstract
The invention relates to aptamers which specifically bind to fibrinogen and their use in the purification of said protein.
Claims21
-16. (canceled)
An aptamer which specifically binds to fibrinogen in a pH-dependent manner.
An aptamer capable of specifically binding to fibrinogen, wherein:
- the aptamer comprises a polynucleotide having at least 70% of sequence identity with the nucleotide sequence of SEQ ID No 66, or
- the aptamer comprises the nucleotide moiety of formula (II):
- 5′-[SEQ ID NO:
- 79]-[X1]SEQ ID NO:
- 77]-[X2]- [SEQ
- ID NO:
- 78]-3′ (III)
- wherein:
- [X2] and [X1] are independently a nucleotide or an oligonucleotide of 2 to 5 nucleotides in length,
- [SEQ ID NO:77] is an oligonucleotide of SEQ ID NO:77 (namely GTTGGTAGGG),
- [SEQ ID NO:78] is an oligonucleotide of SEQ ID NO:78 (namely GGTGTAT), and
- [SEQ ID NO:79] is an oligonucleotide of SEQ ID NO:79 (namely TGT).
9 more elements
Dependencies are inferred from the claim text.